Image-Guided Radiotherapy and Chemotherapy in Gynaecological Cancer

CONCLUSION

• In the present study the results obtained with the use of MRI-GBT in all the women with cervical cancer are comparable to those of the most important multicentre studies reported to date, with scarce, albeit manageable, late toxicity. • The future is leading in the direction of the EMBRACE II study which is aimed at reducing toxicity in women showing good response after radiochemotherapy and intensification of brachytherapy treatment, especially with interstitial brachytherapy in order to improve local control and survival in patients with advanced tumours and poor initial response.